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Background
It has been reported that FMF was more prevalent
among Turkish people whose parental origin came from
central Anatolia.
Objectives
To determine the prevalence of clinically diagnosed
FMF blind to the results of mutation analysis and to
assess the frequency and distribution of MEFV muta-
tions, in Sivas, Zara.
Methods
15906 people live in Zara, a small town of Sivas. To
detect a prevalence of 0.6% with an error of 0.35% and
95% CI, 1673 people were to be screened. One parent
from each house (index person) was directly interviewed
and also questioned for the family members (FM) of the
household with two standard questionnaires. Subjects
were revisited by a group of rheumatologists for 3 times.
Finally they were classified clinically as definite, probable
and possible FMF, blind to genetic analysis. Blood was
drawn from every fifth index case (n=336) to analyze
MEFV-mutations by sequencing and from the definite
and suspected cases of FMF (104/121, 86%).
Results
1727 inhabitants were interviewed directly (index popula-
tion). (M:F=176:1551, mean age: 40.2±11.4). Information
concerning the 4591 family members was obtained via the
index person (M:F=2939:1652, mean age: 33.5±19.6).
According to the results of the first visit, 384/6318
(165 index, 219 FM) had suspected FMF. In the second
visit 368/384 (95.8%) were contacted. A final diagnosis
based on clinical criteria, was obtained after the third
visit (121/368, 47 index, 74 family members). Among
121 patients 68 were considered as definite (68/6318;
1.07%), 21 as probable (21/6318; 0.34%) and 32 as possible
FMF (32/6318; 0.50%). The results of the mutation analysis
were unblinded only after this classification was finalized.
The distribution of patients carrying at least one exon 10
mutation were 32 of the 60 tested (53.3%) in the definite, 5
out of 19 (26.3%) in the probable, and 11 of the 25 (44.0%)
in the possible group. In the general Zara population, 60 of
the 336 tested (17.8%) carried at least one exon 10
mutation.
Conclusions
The minimal prevalence of definite clinical FMF in Zara
was estimated as 1.07%. Only half of the patient group,
as a whole, carried at least one exon 10 mutation. This
was significantly different from the carrier rate of exon
10 mutations in the general population of Zara (1:6).
However, even in a small population like this, MEFV
gene mutations do not seem to be the only explanation
why clinical FMF is so prevalent among people of Zara.
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